Literature DB >> 2912523

Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors.

N L Geller1, G J Bosl, E Y Chan.   

Abstract

Among 216 patients with metastatic germ cell tumors who achieved a complete response (CR) to cisplatin-based chemotherapy (CT), 38 have experienced a relapse. Prognostic factors for time to relapse from time of response were considered using the Cox proportional hazards model. Compared with patients who responded to CT and did not require surgery and patients whose surgery showed only either necrotic debris or mature teratoma, those who required surgery for residual tumor after CT were at much higher risk for relapse, although their residual tumor was totally resected. Of the 19 patients who required this surgery, eight have experienced a relapse. Other prognostic factors for relapse included lactate dehydrogenase (LDH) and human chorionic gonadatropin (hCG) at the time of initial CT. Although those who require surgery for residual tumor after CT receive additional CT, there is still a high risk of relapse.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912523     DOI: 10.1002/1097-0142(19890201)63:3<440::aid-cncr2820630308>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Secondary surgery in germ cell tumors--when and how extensively should it be performed?

Authors:  Richard S Foster; Stephen Beck; Richard Bihrle
Journal:  World J Urol       Date:  2004-03-30       Impact factor: 4.226

2.  Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors.

Authors:  Jörg Thomas Hartmann; Oliver Rick; Karin Oechsle; Markus Kuczyk; Thomas Gauler; Patrick Schöffski; Jan Schleicher; Frank Mayer; Reinhard Teichmann; Lothar Kanz; Carsten Bokemeyer
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 3.  Persistent cancer in postchemotherapy retroperitoneal lymph-node dissection: outcome analysis.

Authors:  J P Donohue; E P Fox; S D Williams; P J Loehrer; T M Ulbright; L H Einhorn; T D Weathers
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

4.  Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.

Authors:  E W Steyerberg; H J Keizer; J Zwartendijk; G L Van Rijk; C J Van Groeningen; J D Habbema; G Stoter
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

5.  Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.

Authors:  A Gerl; C Clemm; N Schmeller; H Dienemann; M Weiss; M Kriegmair; U Löhrs; W Wilmanns
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.